The primary rationale behind dose dense therapy is to improve the efficacy of chemotherapy. By shortening the interval between treatments, the therapy aims to keep the pressure on cancer cells, potentially leading to better outcomes. This is particularly important for aggressive cancers that proliferate rapidly.